Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.

Wattmo C, Wallin ÅK.

Alzheimers Res Ther. 2017 Aug 31;9(1):70. doi: 10.1186/s13195-017-0294-2.

2.

Trajectories of dementia-related cognitive decline in a large mental health records derived patient cohort.

Baker E, Iqbal E, Johnston C, Broadbent M, Shetty H, Stewart R, Howard R, Newhouse S, Khondoker M, Dobson RJB.

PLoS One. 2017 Jun 7;12(6):e0178562. doi: 10.1371/journal.pone.0178562. eCollection 2017.

3.

The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up.

Barocco F, Spallazzi M, Concari L, Gardini S, Pelosi A, Caffarra P.

J Alzheimers Dis. 2017;57(3):775-786. doi: 10.3233/JAD-161264.

4.

Incident Psychosis in Subjects With Mild Cognitive Impairment or Alzheimer's Disease.

Weamer EA, DeMichele-Sweet MA, Cloonan YK, Lopez OL, Sweet RA.

J Clin Psychiatry. 2016 Dec;77(12):e1564-e1569. doi: 10.4088/JCP.15m10617.

5.

Identifying Neurocognitive Decline at 36 Months among HIV-Positive Participants in the CHARTER Cohort Using Group-Based Trajectory Analysis.

Brouillette MJ, Yuen T, Fellows LK, Cysique LA, Heaton RK, Mayo NE.

PLoS One. 2016 May 18;11(5):e0155766. doi: 10.1371/journal.pone.0155766. eCollection 2016.

6.

Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational Study.

Henneges C, Reed C, Chen YF, Dell'Agnello G, Lebrec J.

J Alzheimers Dis. 2016;52(3):1065-80. doi: 10.3233/JAD-150852.

7.

Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline.

Hochstetler H, Trzepacz PT, Wang S, Yu P, Case M, Henley DB, Degenhardt E, Leoutsakos JM, Lyketsos CG.

J Alzheimers Dis. 2016;50(1):271-82. doi: 10.3233/JAD-150563.

8.

Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β.

Cohen ML, Kim C, Haldiman T, ElHag M, Mehndiratta P, Pichet T, Lissemore F, Shea M, Cohen Y, Chen W, Blevins J, Appleby BS, Surewicz K, Surewicz WK, Sajatovic M, Tatsuoka C, Zhang S, Mayo P, Butkiewicz M, Haines JL, Lerner AJ, Safar JG.

Brain. 2015 Apr;138(Pt 4):1009-22. doi: 10.1093/brain/awv006. Epub 2015 Feb 15.

9.

Behavioral and psychological symptoms in Alzheimer's disease.

Li XL, Hu N, Tan MS, Yu JT, Tan L.

Biomed Res Int. 2014;2014:927804. doi: 10.1155/2014/927804. Epub 2014 Jul 15. Review.

10.

Psychotic Alzheimer's disease is associated with gender-specific tau phosphorylation abnormalities.

Koppel J, Acker C, Davies P, Lopez OL, Jimenez H, Azose M, Greenwald BS, Murray PS, Kirkwood CM, Kofler J, Sweet RA.

Neurobiol Aging. 2014 Sep;35(9):2021-8. doi: 10.1016/j.neurobiolaging.2014.03.003. Epub 2014 Mar 6.

11.

TAR DNA-binding protein 43 pathology in Alzheimer's disease with psychosis.

Vatsavayi AV, Kofler J, Demichele-Sweet MA, Murray PS, Lopez OL, Sweet RA.

Int Psychogeriatr. 2014 Jun;26(6):987-94. doi: 10.1017/S1041610214000246. Epub 2014 Mar 4.

12.

Plasma prion protein concentration and progression of Alzheimer disease.

Schmidt C, Becker H, Peter C, Lange K, Friede T, Zerr I.

Prion. 2014 Mar-Apr;8(2). pii: 27964. Epub 2014 Feb 18.

13.

Psychosis in Alzheimer's disease.

Murray PS, Kumar S, Demichele-Sweet MA, Sweet RA.

Biol Psychiatry. 2014 Apr 1;75(7):542-52. doi: 10.1016/j.biopsych.2013.08.020. Epub 2013 Oct 6. Review.

14.

Progression of mild Alzheimer's disease: knowledge and prediction models required for future treatment strategies.

Wattmo C, Wallin AK, Minthon L.

Alzheimers Res Ther. 2013 Oct 7;5(5):44. doi: 10.1186/alzrt210. eCollection 2013.

15.

Effect of Alzheimer's disease risk genes on trajectories of cognitive function in the Cardiovascular Health Study.

Sweet RA, Seltman H, Emanuel JE, Lopez OL, Becker JT, Bis JC, Weamer EA, DeMichele-Sweet MA, Kuller LH.

Am J Psychiatry. 2012 Sep;169(9):954-62. doi: 10.1176/appi.ajp.2012.11121815.

16.

Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set.

Monsell SE, Liu D, Weintraub S, Kukull WA.

Int Psychogeriatr. 2012 Oct;24(10):1553-60. doi: 10.1017/S1041610212000452. Epub 2012 Apr 16.

17.

Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression Study.

Leoutsakos JM, Han D, Mielke MM, Forrester SN, Tschanz JT, Corcoran CD, Green RC, Norton MC, Welsh-Bohmer KA, Lyketsos CG.

Int Psychogeriatr. 2012 Oct;24(10):1561-70. doi: 10.1017/S104161021200049X. Epub 2012 Jun 12.

18.

Trajectory classes of depression in a randomized depression trial of heart failure patients: a reanalysis of the SADHART-CHF trial.

Kuchibhatla MN, Fillenbaum GG.

Am J Geriatr Pharmacother. 2011 Dec;9(6):483-94. doi: 10.1016/j.amjopharm.2011.09.001. Epub 2011 Oct 28.

19.

Genome-wide association study of Alzheimer's disease with psychotic symptoms.

Hollingworth P, Sweet R, Sims R, Harold D, Russo G, Abraham R, Stretton A, Jones N, Gerrish A, Chapman J, Ivanov D, Moskvina V, Lovestone S, Priotsi P, Lupton M, Brayne C, Gill M, Lawlor B, Lynch A, Craig D, McGuinness B, Johnston J, Holmes C, Livingston G, Bass NJ, Gurling H, McQuillin A; GERAD Consortium; National Institute on Aging Late-Onset Alzheimer's Disease Family Study Group, Holmans P, Jones L, Devlin B, Klei L, Barmada MM, Demirci FY, DeKosky ST, Lopez OL, Passmore P, Owen MJ, O'Donovan MC, Mayeux R, Kamboh MI, Williams J.

Mol Psychiatry. 2012 Dec;17(12):1316-27. doi: 10.1038/mp.2011.125. Epub 2011 Oct 18.

20.

Supplemental Content

Support Center